Broadfin Capital, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 98 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2018. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2019$10,564,000
+560.2%
2,688,068
+1378.2%
1.42%
+378.0%
Q3 2019$1,600,000
-80.6%
181,844
-79.6%
0.30%
-83.5%
Q2 2019$8,249,000
-35.7%
891,760
-55.3%
1.80%
-32.2%
Q1 2019$12,827,000
-30.2%
1,994,911
+2.4%
2.65%
+9.7%
Q4 2018$18,365,000
-57.6%
1,947,541
-9.6%
2.42%
-62.2%
Q3 2018$43,360,000
-0.5%
2,153,991
+44.1%
6.38%
-7.0%
Q2 2018$43,595,000
-11.6%
1,494,520
-9.8%
6.86%
-10.7%
Q1 2018$49,337,000
+48.9%
1,656,720
+60.9%
7.69%
+41.9%
Q4 2017$33,141,000
-9.9%
1,029,866
-2.7%
5.42%
-0.5%
Q3 2017$36,802,000
-12.2%
1,058,138
-24.8%
5.44%
+6.9%
Q2 2017$41,913,000
+79.4%
1,407,887
+79.8%
5.09%
+79.9%
Q1 2017$23,369,000
-11.7%
782,887
-48.2%
2.83%
-3.7%
Q4 2016$26,476,000
-23.1%
1,510,316
+4.4%
2.94%
-4.7%
Q3 2016$34,425,000
+67.9%
1,447,053
+12.9%
3.08%
+54.8%
Q2 2016$20,502,000
-15.9%
1,281,373
+10.0%
1.99%
-15.3%
Q1 2016$24,368,000
-22.6%
1,165,3730.0%2.35%
+21.6%
Q4 2015$31,465,000
+3.4%
1,165,373
+6.4%
1.94%
+14.2%
Q3 2015$30,440,000
+63.5%
1,095,373
+44.2%
1.69%
+69.4%
Q2 2015$18,615,000
+44.6%
759,470
+8.0%
1.00%
-0.3%
Q1 2015$12,874,000
-68.9%
703,470
-68.6%
1.00%
-44.2%
Q4 2014$41,378,000
+288.9%
2,242,740
+102.6%
1.80%
+61.3%
Q3 2014$10,639,000
+49.5%
1,107,046
+42.8%
1.12%
+218.6%
Q2 2014$7,118,000
+119.7%
775,442
+158.5%
0.35%
+11.5%
Q1 2014$3,240,000300,0000.31%
Other shareholders

There were no reported owners of LA JOLLA PHARMACEUTICAL CO in Q2 2018.

NameSharesValueWeighting ↓
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders